Skip to main content
. 2021 Jun 25;14:713–725. doi: 10.2147/JAA.S305513

Table 1.

Demographics and Clinical Characteristics of Enrolled Patients*

Characteristic All Enrolled and Completed Data Entry Forms (n = 1884) Completed Enrollment Questionnaires (n = 1109)
Age at enrollment, y
 Mean (SD) 54 (14) 54 (14)
 Median (range) 55 (18, 92) 55 (18, 86)
Female, % 69 70
Race, %
 White 75 80
 Black 19 15
 Other 4 4
 Not reported 2 1
Hispanic or Latino ethnicity, %
 Hispanic or Latino 8 7
 Not Hispanic or Latino 92 93
BMI, kg/m2
 Mean (SD) 33 (9) 33 (9)
 Median (range) 32 (9, 109) 32 (9, 109)
Care by subspecialist at site, %
 Allergist/immunologist 39 43
 Pulmonologist 51 47
 Allergist/immunologist and pulmonologist 10 10
Insurance, %
 Commercial 60 64
 Medicare 23 23
 Medicaid 10 7
 Other† 5 6
 Uninsured 1 1
Residential area, %
 Suburban 50 52
 Urban 26 25
 Rural 20 20
 Missing 4 3
Smoking status, %
 Never 66 68
 Former 30 29
 Current 3 3
Employment status, %
 Employed full-time 39 42
 Employed part-time 6 6
 Self-employed 3 4
 Homemaker 3 3
 Full-time student 2 2
 Retired 22 22
 Disabled due to asthma 8 8
 Disabled due to nonasthma condition 7 6
 Unemployed 6 5
 Missing 4 3
Education level, %
 Some high school or less 5 3
 Graduated high school 23 21
 College 46 48
 Graduate school 17 19
 Missing 9 8
Enrollment treatment class, %
 Uncontrolled on high-dosage ICS/LABA only 30 28
 Any monoclonal antibody 65 67
  Omalizumab 31 34
  Non-omalizumab 32 33
 Systemic corticosteroids or immunosuppressant 14 13
Exacerbations during 12 months prior to enrollment
 Confirmed exacerbations per patient, mean, n 1.2 1.1

Notes: *Percentages may not total 100% as a result of rounding. ”Other” includes “other government insurance” and “other”. ”Unemployed” does not include retired, disabled, or homemaker.

Abbreviations: BMI, body mass index; ICS, inhaled corticosteroid; LABA, long-acting beta agonist; SD, standard deviation.